• Severe renal impairment (eGFR less than 30 mL/min/1.73 m2), end These highlights do not include all the information needed to use stage renal disease, or patients on dialysis. (4, 5.1, 5.2) SEGLUROMET safely and effectively. See full prescribing • Metabolic acidosis, including diabetic ketoacidosis. (4, 5.1) information for SEGLUROMET. • Hypersensitivity to ertugliflozin, metformin or any excipient. (4)
{"title":"Body","authors":"Jarryd Terblanche","doi":"10.2307/j.ctv1b74285.80","DOIUrl":"https://doi.org/10.2307/j.ctv1b74285.80","url":null,"abstract":"• Severe renal impairment (eGFR less than 30 mL/min/1.73 m2), end These highlights do not include all the information needed to use stage renal disease, or patients on dialysis. (4, 5.1, 5.2) SEGLUROMET safely and effectively. See full prescribing • Metabolic acidosis, including diabetic ketoacidosis. (4, 5.1) information for SEGLUROMET. • Hypersensitivity to ertugliflozin, metformin or any excipient. (4)","PeriodicalId":387735,"journal":{"name":"Best New African Poets 2019 Anthology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133993770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：